Expression of Phox2b by Brainstem Neurons Involved in Chemosensory Integration in the Adult Rat
Overview
Authors
Affiliations
Central congenital hypoventilation syndrome is caused by mutations of the gene that encodes the transcription factor Phox2b. The syndrome is characterized by a severe form of sleep apnea attributed to greatly compromised central and peripheral chemoreflexes. In this study, we analyze whether Phox2b expression in the brainstem respiratory network is preferentially associated with neurons involved in chemosensory integration in rats. At the very rostral end of the ventral respiratory column (VRC), Phox2b was present in many VGlut2 (vesicular glutamate transporter 2) mRNA-containing neurons. These neurons were functionally identified as the respiratory chemoreceptors of the retrotrapezoid nucleus (RTN). More caudally in the VRC, many fewer neurons expressed Phox2b. These cells were not part of the central respiratory pattern generator (CPG), because they were typically cholinergic visceral motor neurons or catecholaminergic neurons (presumed C1 neurons). Phox2b was not detected in serotonergic neurons, in the A5, A6, and A7 noradrenergic cell groups nor within the main cardiorespiratory centers of the dorsolateral pons. Phox2b was expressed by many solitary tract nucleus (NTS) neurons including those that relay peripheral chemoreceptor information to the RTN. These and previous observations by others suggest that Phox2b is expressed by an uninterrupted chain of neurons involved in the integration of peripheral and central chemoreception (carotid bodies, chemoreceptor afferents, chemoresponsive NTS neurons projecting to VRC, RTN chemoreceptors). The presence of Phox2b in this circuit and its apparent absence from the respiratory CPG could explain why Phox2b mutations disrupt breathing automaticity during sleep without causing major impairment of respiration during waking.
Molecular Ontology of the Nucleus of Solitary Tract.
Gasparini S, Almeida-Pereira G, Munuzuri A, Resch J, Geerling J J Comp Neurol. 2024; 532(12):e70004.
PMID: 39629676 PMC: 11615840. DOI: 10.1002/cne.70004.
Souza G, Stornetta D, Abbott S J Neurosci. 2024; 45(1).
PMID: 39510833 PMC: 11694402. DOI: 10.1523/JNEUROSCI.1587-24.2024.
Gu B Epilepsy Curr. 2024; 24(4):289-291.
PMID: 39309053 PMC: 11412407. DOI: 10.1177/15357597241253680.
Gonye E, Shi Y, Li K, Clements R, Xu W, Bayliss D J Neurosci. 2024; 44(36).
PMID: 39107057 PMC: 11376338. DOI: 10.1523/JNEUROSCI.0799-24.2024.
Diana D, Pirone L, Russo L, DAbrosca G, Madheswaran M, Benfante R Chem Sci. 2024; 15(23):8858-8872.
PMID: 38873078 PMC: 11168103. DOI: 10.1039/d3sc06427a.